B of A Securities Maintains Buy on Minimed Group, Raises Price Target to $28

Benzinga Newsdesk www.benzinga.com Positive 87.8%

Neg 0% Neu 0% Pos 87.8%

B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $24 to $28.